Carregant...
Screening for Pancreatic Ductal Adenocarcinoma: Are We Asking the Impossible?
Pancreatic cancer is projected to become the second leading cause of cancer-related death in the US by 2020. Because of this, significant interest and research funding has been devoted to development of a screening test to identify individuals during a prolonged asymptomatic period, however, to date...
Guardat en:
| Publicat a: | Cancer Prev Res (Phila) |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8089111/ https://ncbi.nlm.nih.gov/pubmed/33148677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-20-0426 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|